Redmile Group’s GenMark Diagnostics, Inc GNMK Stock Holding History

Redmile Group’s Portfolio GNMK Stock Details GNMK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-3,589,342	Closed	-$85.8M	–	93
2021 Q1	$85.8M	Sell	3,589,342 -948,058	-21%	-$17.6M	1.21%	26
2020 Q4	$66.2M	Sell	4,537,400 -176,200	-4%	-$2.34M	0.8%	40
2020 Q3	$66.9M	Sell	4,713,600 -189,800	-4%	-$2.9M	1.23%	28
2020 Q2	$72.1M	Buy	+4,903,400	New	+$49.8M	1.33%	23

Redmile Group's GNMK Position: Q2 2021 in Review

Redmile Group sold out of GenMark Diagnostics, Inc (GNMK) in Q2 2021, closing a stake of 3,589,342 shares — an estimated $85.8M sold.

Redmile Group first reported a position in GNMK in Q2 2020 and held it in 4 quarters. The position peaked at $85.8M in Q1 2021. 0 funds tracked by Wall St. Rank hold GNMK as of Q2 2021.

Redmile Group reported no remaining GenMark Diagnostics, Inc position as of Q2 2021 after selling out during the quarter.
Redmile Group sold 3,589,342 GenMark Diagnostics, Inc shares in Q2 2021, an estimated $85.8M.
Redmile Group first reported a position in GenMark Diagnostics, Inc in Q2 2020 and held it in 4 quarters.
Redmile Group's GenMark Diagnostics, Inc position peaked at $85.8M in Q1 2021.
0 funds tracked by Wall St. Rank held GenMark Diagnostics, Inc as of Q2 2021.

Based on Redmile Group's 13F filing for Q2 2021, filed 16 Aug 2021.